EUVIMEDEUVIMED entdecken
Crossref

Synthesis and growth inhibitory activity of sinomenine derivatives against cervical cancer SiHa cells through targeting the AKT-CyclinD1-p21/p27 pathway

Haozhe Yang, Xiaorui Li, Zhaoning Cai, Yueqing Li, Zhigang Gao, Shisheng Wang, Xiuhan Guo

Medicinal Chemistry Research · 2026-07 · 35 (7) · 1341-1351

DOI: 10.1007/s00044-026-03584-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicinal Chemistry Research, online erschienen am 08.06.2026. Verfasst von Haozhe Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Engineering, School of Chemical Engineering, Dalian University of Technology, Dalian, 116024, China. Hauptthemen laut MEDLINE: Morphinans, Uterine Cervical Neoplasms, Proto-Oncogene Proteins c-akt, Antineoplastic Agents. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Natural Science Foundation of Liaoning Province, Fundamental Research Funds for the Central Universities of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer remains a leading cause of female malignancy worldwide, with current therapies limited by systemic toxicity and inadequate efficacy. Sinomenine, a natural isoquinoline alkaloid derived from Sinomenium acutum, exhibits moderate anticancer potential but requires structural modification to enhance its activity. Herein, we synthesized 15 sinomenine derivatives via Ritter reaction-mediated amidation of the C-1 hydroxymethyl group and esterification of the C-4 phenolic hydroxyl group. The in vitro anticancer activities of these derivatives were evaluated against three cervical cancer cell lines (HeLa, SiHa, and C33A) using MTT assay. Among them, compound S14 displayed the most potent cytotoxicity, with IC₅₀ values of 3.32 ± 0.31 µM, 1.96 ± 0.08 µM, and 6.20 ± 0.55 µM against HeLa, SiHa, and C33A cells, respectively. Colony formation, wound healing, and Transwell experiments demonstrated that S14 inhibited the proliferation, migration, and invasion of SiHa cells in a concentration-dependent manner. Flow cytometry assays revealed that S14 induced G₂/M phase cell cycle arrest and late apoptosis in SiHa cells. Mechanistically, Western blot assays indicated that S14 downregulated the expression of AKT, phosphorylated AKT (p-AKT), and CyclinD1, while upregulating the cyclin-dependent kinase inhibitors p21 and p27, suggesting the involvement of the AKT-CyclinD1-p21/p27 signaling pathway. Moreover, AKT silencing via siRNA transfection significantly attenuated S14-induced cell cycle arrest and apoptosis. Collectively, these findings highlight that S14, a structurally optimized sinomenine derivative, exerts anticancer effects by targeting the AKT-CyclinD1-p21/p27 pathway, and thus holds promise as a potential therapeutic candidate for cervical cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MorphinansUterine Cervical NeoplasmsProto-Oncogene Proteins c-aktAntineoplastic AgentsHumansFemaleCyclin-Dependent Kinase Inhibitor p27Cell ProliferationCyclin D1Cell Line, TumorCyclin-Dependent Kinase Inhibitor p21Signal TransductionApoptosisDrug Screening Assays, AntitumorStructure-Activity RelationshipDose-Response Relationship, Drug

Stichwörter der Autor:innen

AKT signaling pathwayAnticancer activityCervical cancerSinomenine derivativesStructural modification

Substanzen

sinomenineMorphinansProto-Oncogene Proteins c-aktAntineoplastic AgentsCyclin-Dependent Kinase Inhibitor p27Cyclin D1Cyclin-Dependent Kinase Inhibitor p21CCND1 protein, human

Autor:innen und Institutionen

  • Department of Pharmaceutical Engineering, School of Chemical Engineering, Dalian University of Technology, Dalian, 116024, China.
  • Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, 110042, China.
  • Ningbo Institute of Dalian University of Technology, Ningbo, 315016, China.
  • Department of Pharmaceutical Engineering, School of Chemical Engineering, Dalian University of Technology, Dalian, 116024, China. wangss@dlut.edu.cn.
  • Ningbo Institute of Dalian University of Technology, Ningbo, 315016, China. wangss@dlut.edu.cn.
  • Department of Pharmaceutical Engineering, School of Chemical Engineering, Dalian University of Technology, Dalian, 116024, China. kakumicin@dlut.edu.cn.

Förderung

  • Natural Science Foundation of Liaoning Province
  • Fundamental Research Funds for the Central Universities of China
  • National Natural Science Foundation of China

Zitieren

APA

Yang, H., Li, X., Cai, Z., Li, Y., Gao, Z., Wang, S., & Guo, X. (2026). Synthesis and growth inhibitory activity of sinomenine derivatives against cervical cancer SiHa cells through targeting the AKT-CyclinD1-p21/p27 pathway. Medicinal Chemistry Research, 35(7), 1341-1351. https://doi.org/10.1007/s00044-026-03584-9

Vancouver

Yang H, Li X, Cai Z, Li Y, Gao Z, Wang S, et al. Synthesis and growth inhibitory activity of sinomenine derivatives against cervical cancer SiHa cells through targeting the AKT-CyclinD1-p21/p27 pathway. Medicinal Chemistry Research. 2026;35(7):1341-1351. doi:10.1007/s00044-026-03584-9

BibTeX
@article{Yang2026,
  author = {Yang, Haozhe and Li, Xiaorui and Cai, Zhaoning and Li, Yueqing and Gao, Zhigang and Wang, Shisheng and Guo, Xiuhan},
  title = {Synthesis and growth inhibitory activity of sinomenine derivatives against cervical cancer SiHa cells through targeting the AKT-CyclinD1-p21/p27 pathway},
  journal = {Medicinal Chemistry Research},
  year = {2026},
  volume = {35},
  number = {7},
  pages = {1341--1351},
  doi = {10.1007/s00044-026-03584-9}
}
Kostenlos starten →